Effect of Exenatide Twice Daily and Dapagliflozin, Alone and in Combination, on Markers of Kidney Function in Obese Patients with Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Controlled Clinical Trial
Diabetes Obesity and Metabolism（2021）
Key words
dapagliflozin,diabetic kidney disease,exenatide,GLP-1RA,glucagon-like peptide-1 receptor agonists,SGLT2 inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined